Jun 212018
 

By operator Feed Up

Talent4Boards - Great Talent builds Great Boards

– UK, Brighton – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR), announces the appointment of Nick Rodgers as an independent Non-Executive Director with immediate effect.… => Read full post

Destiny Pharma appoints Nick Rodgers to its Board as Independent Non-Executive Director

From:: Destiny Pharma appoints Nick Rodgers to its Board as Independent Non-Executive Director

Sorry, the comment form is closed at this time.

%d bloggers like this: